The main interest in the Eskeland lab is to understand how gene activity is regulated by local composition (histone modifications and variants), chromatin structure and nuclear organisation. We uniquely combine in vitro and in vivo approaches to study these epigenetic mechanisms during in embryonic stem cell differentiation, in cancer cells and after exposure to drugs.
Eskeland is an Associate Professor at Department of Molecular Medicine, in the leader team of PharmaTox strategic research initiative and a partner PI in the Centre for Cancer Cell Reprogramming.
Learn more about Cancer Epigenetics and our research in our YouTube channel.